L Morandi
Overview
Explore the profile of L Morandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
2161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gherardi S, Bovolenta M, Passarelli C, Falzarano M, Pigini P, Scotton C, et al.
Biochim Biophys Acta Gene Regul Mech
. 2020 Nov;
1863(11):194646.
PMID: 33144059
No abstract available.
2.
Kuijvenhoven J, Livi V, Morandi L, Cancellieri A, Annema J, Trisolini R
Lung Cancer
. 2019 Jul;
134:194-201.
PMID: 31319981
Objectives: Tissue acquisition of lung tumors is crucial for diagnostic and treatment purposes. In patients with centrally located lung tumors without endobronchial abnormalities the yield of conventional bronchoscopy is poor....
3.
Gabusi A, Morandi L, Asioli S, Foschini M
Pathologica
. 2017 Jun;
109(1):60-65.
PMID: 28635994
Notwithstanding extended surgical approaches or adjuvant chemoradiotherapy, the development of multiple neoplastic lesions arising in the oral cavity after treatment still represents a critical clinical challenge in the management of...
4.
Ripolone M, Violano R, Ronchi D, Mondello S, Nascimbeni A, Colombo I, et al.
Neuropathol Appl Neurobiol
. 2017 Jun;
44(5):449-462.
PMID: 28574618
Aims: Pompe disease is an autosomal recessive lysosomal storage disorder resulting from deficiency of acid α-glucosidase (GAA) enzyme. Histopathological hallmarks in skeletal muscle tissue are fibre vacuolization and autophagy. Since...
5.
Gissi D, Tarsitano A, Leonardi E, Gabusi A, Neri F, Marchetti C, et al.
Oral Oncol
. 2017 Mar;
67:131-137.
PMID: 28351567
Objectives: A novel classification based on molecular methods to assess clonality defines three types of secondary oral squamous cell carcinoma (OSCC): second primary tumour (SPT) independent from the index tumour,...
6.
Asioli S, Morandi L, Cavatorta C, Cucchi M, Foschini M
Eur J Surg Oncol
. 2016 Aug;
42(12):1806-1813.
PMID: 27546014
Aim: Aim of the present study is to evaluate the risk of residual neoplastic foci, in patients treated with breast conservative surgery, based on duct carcinoma in situ (DCIS) grading....
7.
Fiorillo C, Astrea G, Savarese M, Cassandrini D, Brisca G, Trucco F, et al.
Orphanet J Rare Dis
. 2016 Jul;
11(1):91.
PMID: 27387980
Background: Myosin heavy chain 7 (MYH7)-related myopathies are emerging as an important group of muscle diseases of childhood and adulthood, with variable clinical and histopathological expression depending on the type...
8.
Marucci G, Fabbri P, Morandi L, de Biase D, Di Oto E, Tallini G, et al.
Pathologica
. 2015 Nov;
107(1):1-8.
PMID: 26591624
Introduction: Glioblastoma (GBM) is the most frequent primary malignant brain tumour. Despite advances in treatment its prognosis remains poor. Histological features of GBM are well known. On the contrary histological...
9.
Imbrici P, Maggi L, Mangiatordi G, Dinardo M, Altamura C, Brugnoni R, et al.
J Physiol
. 2015 Jun;
593(18):4181-99.
PMID: 26096614
Key Points: Loss-of-function mutations of the skeletal muscle ClC-1 channel cause myotonia congenita with variable phenotypes. Using patch clamp we show that F484L, located in the conducting pore, probably induces...
10.
Brandes A, Franceschi E, Ermani M, Tosoni A, Albani F, Depenni R, et al.
Neurooncol Pract
. 2015 Jun;
1(4):166-171.
PMID: 26034628
Background: As yet, no population-based prospective studies have been conducted to investigate the incidence and clinical outcome of glioblastoma (GBM) or the diffusion and impact of the current standard therapeutic...